Skip to main content
Signal8

VOLITIONRX LTD (VNRX)

VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes. It also provides Nu.Q Cancer for predicting treatment response, monitoring treatment response and disease progression, and amending a patient's cancer treatment regimen; and Capture-PCR and Capture-Seq, which are isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection. VolitionRx Limited is headquartered in Henderson, Nevada.

Sector: In Vitro & In Vivo Diagnostic Substances

Industry: Medical - Devices

VolitionRX Ltd logo

VolitionRX Ltd

NYSE:VNRXHealthcare
-5.56%$0.1887
CLOSED
AH$0.1801-4.56%vs close
Mkt Cap$6.81M
EV-
Float35.56M
O/S36.08M
VOL3.08M sh
$ Vol$597K
RVOL0.81×
Inst Own7.5%
SI3.9%
Net Cash/Sh-
Dilution
VolitionRX Ltd logoNYSE:VNRXClosed$0.1887-5.56%
Short interest (FINRA)
3.9%
Oct 30 (19d)

Float 35.56M · Signal8 dilution snapshot · Nov 12, 2026

1.4M
Oct 30 (19d)prev 1.1M▲ 21.9%
1.19
Oct 30 (19d)prev 1.00▲ 19.0%
Borrow (IBKR)

The cost to borrow VNRX shares for a short sale and how many IBKR has available, from IBKR's lendable-stock file, refreshed through the session.

IBKR borrow fee and availability is included in Signal8 ProUpgrade to Pro · $40.67/mo billed annually
Off-exchange & settlement
52.9%
Nov 17 (1d)prev 48.9%▲ 4.0 pts

Off-exchange short volume is not short interest and is not a bearish signal. When a wholesaler fills a retail buy order it sells to the customer as principal and buys back in the market, and that sale is reported as short. A high reported short share is therefore characteristic of internalised retail buying, and this figure should not be read as investors positioning against the stock.

42.0K
Oct 30 (19d)prev 469▲ 8860.6%
Price, short interest & fails to deliver
Short interest · today's share basis23 settlements
Fails to deliver24 settlement dates
Latest short interest settlements (today's share basis)
DateShares short
Oct 30, 20261.4M sh
Oct 15, 20261.1M sh
Sep 30, 20261.2M sh
Sep 15, 20261.0M sh
Aug 31, 20262.2M sh
Latest fails to deliver
DateShares failed
Oct 30, 202642.0K sh
Oct 28, 2026469 sh
Oct 27, 202631.8K sh
Oct 26, 202610.9K sh
Oct 22, 202615.4K sh

A stock split executed inside this window; every settlement plotted has been carried onto today’s share basis, so the line does not step at the split.

The three panels share one date axis, so a point's position is its date; each has its own value axis. Short interest is plotted on today's share basis, so the line does not step where a split does.

Off-exchange short volume
Nov 17
Latest sessions
DateReported short
Nov 17, 202652.9%
Nov 16, 202648.9%
Nov 13, 202653.9%
Nov 12, 202652.3%
Nov 11, 202649.8%
91-session median 49.8%mean 48.4%range 21.6–78.3%

130 calendar days requested; 92 sessions published. FINRA reports this at T+1 to T+2, so the latest session is not today's.

Source: FINRA Reg SHO daily short volume, summed across the NASDAQ, NYSE and Consolidated trade reporting facilities. Covers off-exchange (over-the-counter) executions only; volume executed on an exchange is not included and is not reported short here.

Off-exchange short volume is not short interest and is not a bearish signal. When a wholesaler fills a retail buy order it sells to the customer as principal and buys back in the market, and that sale is reported as short. A high reported short share is therefore characteristic of internalised retail buying, and this figure should not be read as investors positioning against the stock.

ATS venues (dark pools)

FINRA's weekly alternative trading system (dark pool) volume for VNRX: the share of off-exchange volume that traded on an ATS, and each venue by shares and trades.

The ATS venue breakdown is included in Signal8 ProUpgrade to Pro · $40.67/mo billed annually

As of the Oct 30, 2026 FINRA settlement, 1,396,747 VNRX shares were sold short (3.93% of a 35.56M-share float, 1.19 days to cover).